Private Capital Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Private Capital Group’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-89	Closed	-$2K	–	2496
2019 Q2	$2K	Buy	+89	New	+$796	﹤0.01%	1938
2018 Q4	–	Sell	-89	Closed	-$1K	–	2372
2018 Q3	$1K	Hold	89	–	–	﹤0.01%	2122
2018 Q2	$1K	Buy	+89	New	+$1.65K	﹤0.01%	2070

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Private Capital Group's SPPI Position: Q3 2019 in Review

Private Capital Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2019, closing a stake of 89 shares — an estimated $2K sold.

Private Capital Group first reported a position in SPPI in Q2 2018 and held it in 3 quarters. The position peaked at $2K in Q2 2019. 167 funds tracked by Wall St. Rank hold SPPI as of Q3 2019.

Private Capital Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2019 after selling out during the quarter.
Private Capital Group sold 89 Spectrum Pharmaceuticals Inc shares in Q3 2019, an estimated $2K.
Private Capital Group first reported a position in Spectrum Pharmaceuticals Inc in Q2 2018 and held it in 3 quarters.
Private Capital Group's Spectrum Pharmaceuticals Inc position peaked at $2K in Q2 2019.
167 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2019.

Based on Private Capital Group's 13F filing for Q3 2019, filed 13 Nov 2019.